Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate
Thomas Luke, Richard S. Bennett, Dawn M. Gerhardt, et al.
The Journal of Infectious Diseases (2018) Vol. 218, Iss. suppl_5, pp. S636-S648
Open Access | Times Cited: 20

Showing 20 citing articles:

Review: Insights on Current FDA-Approved Monoclonal Antibodies Against Ebola Virus Infection
Olivier Tshiani Mbaya, Philippe Mukumbayi, Sabue Mulangu
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 47
Randomized, Blinded, Dose-Ranging Trial of an Ebola Virus Glycoprotein Nanoparticle Vaccine With Matrix-M Adjuvant in Healthy Adults
Louis Fries, Iksung Cho, Verena Krähling, et al.
The Journal of Infectious Diseases (2019) Vol. 222, Iss. 4, pp. 572-582
Open Access | Times Cited: 41
Enrichment post-library preparation enhances the sensitivity of high-throughput sequencing-based detection and characterization of viruses from complex samples
Adrian C. Paskey, Kenneth G. Frey, Gary P. Schroth, et al.
BMC Genomics (2019) Vol. 20, Iss. 1
Open Access | Times Cited: 37
Human immunoglobulin from transchromosomic bovines hyperimmunized with SARS-CoV-2 spike antigen efficiently neutralizes viral variants
Zhuoming Liu, Hua Wu, Kristi A. Egland, et al.
Human Vaccines & Immunotherapeutics (2021) Vol. 18, Iss. 2
Open Access | Times Cited: 25
Single-cell profiling of lncRNA expression during Ebola virus infection in rhesus macaques
Luisa Santus, Maria Sopena-Rios, Raquel García-Pérez, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Protection of human ACE2 transgenic Syrian hamsters from SARS CoV-2 variants by human polyclonal IgG from hyper-immunized transchromosomic bovines
Theron Gilliland, Yanan Liu, Rong Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 22
Comparative Transcriptomics in Ebola Makona-Infected Ferrets, Nonhuman Primates, and Humans
Robert W. Cross, Emily Speranza, Viktoriya Borisevich, et al.
The Journal of Infectious Diseases (2018)
Open Access | Times Cited: 26
Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection
Bronwyn M. Gunn, Shuangyi Bai
Human Vaccines & Immunotherapeutics (2021) Vol. 17, Iss. 11, pp. 4328-4344
Open Access | Times Cited: 19
Transchromosomic bovine-derived anti-SARS-CoV-2 polyclonal human antibodies protects hACE2 transgenic hamsters against multiple variants
Theron Gilliland, Matthew Dunn, Yanan Liu, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107764-107764
Open Access | Times Cited: 6
Transchromosomic bovines‐derived broadly neutralizing antibodies as potent biotherapeutics to counter important emerging viral pathogens with a special focus on SARS‐CoV‐2, MERS‐CoV, Ebola, Zika, HIV‐1, and influenza A virus
AbdulRahman A. Saied, Manuela Sales Lima Nascimento, Adriano Henrique do Nascimento Rangel, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 10, pp. 4599-4610
Open Access | Times Cited: 10
Equine-Origin Immunoglobulin Fragments Protect Nonhuman Primates from Ebola Virus Disease
Hualei Wang, Gary Wong, Wenjun Zhu, et al.
Journal of Virology (2018) Vol. 93, Iss. 5
Open Access | Times Cited: 18
Increased Antibody Avidity and Cross-Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Variants by Hyperimmunized Transchromosomic Bovine–Derived Human Immunoglobulins for Treatment of Coronavirus Disease 2019
Juanjie Tang, Gabrielle Grubbs, Youri Lee, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 4, pp. 655-663
Open Access | Times Cited: 9
Antibody Therapy: From Diphtheria to Cancer, COVID-19, and Beyond
Deepak Kumar, Sulgey Gauthami, Jagadeesh Bayry, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy (2021) Vol. 40, Iss. 2, pp. 36-49
Open Access | Times Cited: 8
Human immunoglobulin from transchromosomic bovines hyperimmunized with SARS-CoV-2 spike antigen efficiently neutralizes viral variants
Zhuoming Liu, Hua Wu, Kristi A. Egland, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 6
Characterization of the therapeutic effect of antibodies targeting the Ebola glycoprotein using a novel BSL2-compliant rVSVΔG-EBOV-GP infection model
Hana Lee, Ian L. McWilliams, Aaron P. Lewkowicz, et al.
Emerging Microbes & Infections (2021) Vol. 10, Iss. 1, pp. 2076-2089
Open Access | Times Cited: 6
Preclinical evaluation of a fully human, quadrivalent-hantavirus polyclonal antibody derived from a non-human source
Rebecca L. Brocato, Hua Wu, Steven A. Kwilas, et al.
mBio (2024)
Open Access
Polyclonal Antibodies Derived from Transchromosomic Bovines Vaccinated with the Recombinant F1-V Vaccine Increase Bacterial Opsonization In Vitro and Protect Mice from Pneumonic Plague
Sergei S. Biryukov, Hua Wu, Jennifer L. Dankmeyer, et al.
Antibodies (2023) Vol. 12, Iss. 2, pp. 33-33
Open Access | Times Cited: 1
Transgenic Animals for the Generation of Human Antibodies
Biao Ma, Michael J. Osborn
Learning materials in biosciences (2020), pp. 97-127
Closed Access | Times Cited: 2
Une biopharma contre Ebola
Jean-Marie Manus
Revue Francophone des Laboratoires (2018) Vol. 2018, Iss. 505, pp. 13-13
Closed Access
In vivo single-cell profiling of lncRNAs during Ebola virus infection
Luisa Santus, Raquel García-Pérez, Maria Sopena-Rios, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top